₹10 crore (USD 1.2 million) seed round has been successfully raised by Bengaluru based Lumov, an emerging powerhouse in India’s orthopaedic rehabilitation and recovery ecosystem. In addition to QRG Investments & Holdings (Havells Family Office), IIMA Ventures, SIDBI, and a robust network of well-known angel investors, including Ashish Gupta (Helion Advisors), Saket Narang (Steinberg India), Abhishek Goyal (Tracxn), Arjun Vaidya, Indian Silicon Valley, Mapaex Family Office, and several others, Incubate Fund Asia led the funding.
Addressing India’s Expanding MSK Healthcare Burden The investment comes at a crucial time since musculoskeletal (MSK) problems are rapidly increasing in India. One of the biggest new health issues in the nation is being caused by rising levels of sedentary behavior, longer life expectancy, more orthopaedic procedures, and low consumer knowledge of early MSK intervention. The orthotics and rehabilitation sector is still underdeveloped and has long relied on expensive foreign imports or low-quality mass items, despite the fact that the domestic medical devices industry is expected to reach USD 50 billion by 2030. By creating clinically proven, India first products that blend cutting-edge design with easily accessible recovery assistance, Lumov aims to close this gap.
Funding to Accelerate Product Expansion and Market Reach Lumov intends to use the additional funding to develop stronger partnerships with orthopaedic doctors, broaden its product pipeline, and increase production of recovery oriented braces and rehabilitation tools. As part of the next phase of expansion and operational build-out, the company will expand its 15-person staff and bolster its presence in major healthcare cities including Delhi NCR, Mumbai, and Hyderabad.
Founders With Strong Clinical and Investment Backgrounds Founded by Saumaric Dangwal and Ankit Gupta, alumnus of Harvard Business School and IIT Kharagpur, Lumov has a solid domain understanding supported by exposure to international healthcare investing. While Ankit worked for Brookfield Private Equity and Steinberg Asset Management, Saumaric previously oversaw consumer and healthcare investments at Bain Capital. The founders have managed over USD 1.5 billion in healthcare portfolios collectively, giving them a thorough understanding of clinical gaps, prospects for device innovation, and long-term patient recovery requirements. Co-Founders Saumaric and Ankit shared their idea, saying, “India is fighting an orthopaedic health crisis.” Recovery solutions are still lagging behind, although diagnostic breakthroughs are helping. Our goal is to provide top-notch orthotics, post operative aids, and pain management technologies that enable patients to recover more quickly and resume active, pain-free lives.
Market Confidence and Investor Support
Partner at Incubate Fund Asia Rajeev Ranka offered significant support for Lumov’s strategy, pointing out that MSK care is ready for ground-breaking innovation, particularly in the areas of recurrent pain management and post-surgery rehabilitation. Lumov is well-positioned to lead the market thanks to its clinical integration and design-driven methodology.
Ramesh Sharma, President of QRG Investments & Holdings, echoed this confidence by saying that Lumov has a long-term advantage in influencing the MSK device market in India because of its clear vision, quick execution, and surgeon-led development. Conclusion
Lumov is poised to revolutionize the orthopedic care market in India with new funding, clinical alliances, and a research-led product philosophy. The company is well positioned to become a leader in musculoskeletal recovery and pain treatment due to its emphasis on high-end rehabilitation products, scalable manufacturing, and national expansion.
Read the full article here
